🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 03770Y107
- IPO
- 7/31/2026 · $16.00/share
Business: Apnimed, Inc is a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases.
Company Contact
- CEO
- Lawrence G. Miller
- CFO
- Regina M. Marek
- Headquarters
- 39 John F. Kennedy Street, 4th Floor, Cambridge, MA 02138
- Phone
- 617-500-8880
- Investor Relations
- ir@apnimed.com